BCAL Diagnostics Limited(AU:BDX)
A$0.06-0.00 (-4.48%)
AU:BDX
BCAL Diagnostics Limited financials statements
A$0.06
At close:-0.00 (-4.48%)
Want to see AU:BDX full AI Analyst Report?
BCAL Diagnostics Limited (BDX) Ratios
7 Followers
BCAL Diagnostics Limited Ratios
AU:BDX's free cash flow for Q4 2026 was AU$-3.67M. For the 2026 fiscal year, AU:BDX's free cash flow was decreased by AU$-6.63K and operating cash flow was AU$-3.66M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.36 | 2.32 | 3.60 | 2.74 | 11.00 |
| Quick Ratio | 1.36 | 2.32 | 3.60 | 2.74 | 10.18 |
| Cash Ratio | 0.53 | 1.46 | 2.49 | 1.40 | 5.86 |
| Solvency Ratio | -0.78 | -1.69 | -1.64 | -1.57 | -3.54 |
| Operating Cash Flow Ratio | -2.05 | -1.97 | -1.74 | -2.68 | -3.39 |
| Short-Term Operating Cash Flow Coverage | -3.45 | -3.89 | -18.76 | -36.75 | 0.00 |
| Net Current Asset Value | AU$ -4.41M | AU$ 3.51M | AU$ 5.66M | AU$ 3.04M | AU$ 9.50M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.90 | 0.24 | 0.12 | 0.13 | 0.00 |
| Debt-to-Equity Ratio | -8.37 | 0.38 | 0.18 | 0.20 | 0.00 |
| Debt-to-Capital Ratio | 1.14 | 0.28 | 0.15 | 0.17 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 1.20 | 0.02 | 0.04 | 0.00 | 0.00 |
| Financial Leverage Ratio | -9.27 | 1.59 | 1.43 | 1.61 | 1.10 |
| Debt Service Coverage Ratio | -3.05 | -2.14 | -7.68 | -27.31 | 0.00 |
| Interest Coverage Ratio | -27.09 | -108.26 | -54.51 | -291.40 | 0.00 |
| Debt to Market Cap | 0.24 | 0.07 | 0.02 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 |
| Net Debt to EBITDA | -0.61 | 0.35 | 0.87 | 0.27 | 1.37 |
| Profitability Margins | |||||
| Gross Profit Margin | -292.98% | 100.00% | 100.00% | 100.00% | 97.13% |
| EBIT Margin | -5145.88% | -33254.67% | -194.54% | -280.81% | -568.48% |
| EBITDA Margin | -4752.90% | -28623.89% | -182.91% | -276.74% | -565.62% |
| Operating Profit Margin | -5145.88% | -46043.03% | -175.82% | -167.48% | -421.26% |
| Pretax Profit Margin | -5227.79% | -33465.98% | -304.93% | -181.39% | -471.08% |
| Net Profit Margin | -4038.97% | -33465.98% | -206.58% | -181.39% | -471.08% |
| Continuous Operations Profit Margin | -4038.97% | -21316.87% | -206.58% | -181.39% | -471.08% |
| Net Income Per EBT | 77.26% | 100.00% | 67.75% | 100.00% | 100.00% |
| EBT Per EBIT | 101.59% | 72.68% | 173.43% | 108.30% | 111.82% |
| Return on Assets (ROA) | -96.21% | -73.08% | -52.18% | -60.47% | -31.97% |
| Return on Equity (ROE) | 892.23% | -116.40% | -74.52% | -97.08% | -35.12% |
| Return on Capital Employed (ROCE) | -201.56% | -146.48% | -56.33% | -76.49% | -31.41% |
| Return on Invested Capital (ROIC) | -112.57% | -73.79% | -36.49% | -32.56% | -24.91% |
| Return on Tangible Assets | -96.21% | -73.21% | -52.34% | -60.47% | -31.97% |
| Earnings Yield | -26.74% | -31.96% | -18.57% | -34.29% | -20.72% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.08 | 3.12 | 89.67 | 2509.48 | 0.91 |
| Payables Turnover | 1.14 | 0.00 | 0.00 | 0.00 | 0.07 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| Fixed Asset Turnover | 0.09 | 0.01 | 1.06 | 1.29 | 5.32 |
| Asset Turnover | 0.02 | 0.00 | 0.25 | 0.33 | 0.07 |
| Working Capital Turnover Ratio | 0.07 | 0.00 | 0.58 | 0.42 | 0.11 |
| Cash Conversion Cycle | 4436.92 | 116.97 | 4.07 | 0.15 | 9312.82 |
| Days of Sales Outstanding | 4757.86 | 116.97 | 4.07 | 0.15 | 402.92 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 13819.64 |
| Days of Payables Outstanding | 320.94 | 0.00 | 0.00 | 0.00 | 4909.74 |
| Operating Cycle | 4757.86 | 116.97 | 4.07 | 0.15 | 14222.57 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 |
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.03 | -0.04 |
| Dividend Paid and CapEx Coverage Ratio | -13.42 | -7.79 | -3.93 | -16.69 | -0.80 |
| Capital Expenditure Coverage Ratio | -13.42 | -7.79 | -3.93 | -16.69 | -0.80 |
| Operating Cash Flow Coverage Ratio | -0.89 | -2.58 | -2.97 | -5.70 | 0.00 |
| Operating Cash Flow to Sales Ratio | -33.75 | -283.58 | -1.46 | -2.17 | -4.48 |
| Free Cash Flow Yield | -24.01% | -30.56% | -16.46% | -43.42% | -44.33% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.73 | -3.13 | -5.38 | -2.92 | -4.83 |
| Price-to-Sales (P/S) Ratio | 151.05 | 1047.03 | 11.12 | 5.29 | 22.74 |
| Price-to-Book (P/B) Ratio | -33.37 | 3.64 | 4.01 | 2.83 | 1.70 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.16 | -3.27 | -6.07 | -2.30 | -2.26 |
| Price-to-Operating Cash Flow Ratio | -4.48 | -3.69 | -7.62 | -2.44 | -5.08 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.14 | -0.65 | -0.07 | -0.04 |
| Enterprise Value Multiple | -3.79 | -3.31 | -5.21 | -1.64 | -2.65 |
| Enterprise Value | 32.90M | 20.51M | 29.51M | 12.65M | 10.77M |
| EV to EBITDA | -3.79 | -3.31 | -5.21 | -1.64 | -2.65 |
| EV to Sales | 180.24 | 947.95 | 9.53 | 4.53 | 14.99 |
| EV to Free Cash Flow | -4.97 | -2.96 | -5.20 | -1.97 | -1.49 |
| EV to Operating Cash Flow | -5.34 | -3.34 | -6.53 | -2.09 | -3.35 |
| Tangible Book Value Per Share | -0.00 | 0.02 | 0.03 | 0.02 | 0.05 |
| Shareholders’ Equity Per Share | -0.00 | 0.02 | 0.03 | 0.02 | 0.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.36 | 0.32 | 0.55 | 0.21 |
| Revenue Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Net Income Per Share | -0.02 | -0.02 | -0.03 | -0.02 | -0.02 |
| Tax Burden | 0.77 | 1.00 | 0.68 | 1.00 | 1.00 |
| Interest Burden | 1.02 | 1.01 | 1.57 | 0.65 | 0.83 |
| Research & Development to Revenue | 25.60 | 72.62 | 1.41 | 1.60 | 2.66 |
| SG&A to Revenue | 22.93 | 248.89 | 0.53 | 0.84 | 2.60 |
| Stock-Based Compensation to Revenue | 0.00 | 32.05 | 0.19 | 0.08 | 0.51 |
| Income Quality | 0.84 | 0.85 | 0.71 | 1.19 | 0.95 |
Currency in AUD
